Marketing of commercial milk formula : a system to capture parents, communities, science, and policy
© 2023 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL..
Despite proven benefits, less than half of infants and young children globally are breastfed in accordance with the recommendations of WHO. In comparison, commercial milk formula (CMF) sales have increased to about US$55 billion annually, with more infants and young children receiving formula products than ever. This Series paper describes the CMF marketing playbook and its influence on families, health professionals, science, and policy processes, drawing on national survey data, company reports, case studies, methodical scoping reviews, and two multicountry research studies. We report how CMF sales are driven by multifaceted, well resourced marketing strategies that portray CMF products, with little or no supporting evidence, as solutions to common infant health and developmental challenges in ways that systematically undermine breastfeeding. Digital platforms substantially extend the reach and influence of marketing while circumventing the International Code of Marketing of Breast-milk Substitutes. Creating an enabling policy environment for breastfeeding that is free from commercial influence requires greater political commitment, financial investment, CMF industry transparency, and sustained advocacy. A framework convention on the commercial marketing of food products for infants and children is needed to end CMF marketing.
| Errataetall: |
CommentIn: Lancet. 2023 Aug 5;402(10400):445-446. - PMID 37543413 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:401 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 401(2023), 10375 vom: 11. Feb., Seite 486-502 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rollins, Nigel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.02.2023 Date Revised 07.08.2023 published: Print-Electronic CommentIn: Lancet. 2023 Aug 5;402(10400):445-446. - PMID 37543413 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(22)01931-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352740744 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352740744 | ||
| 003 | DE-627 | ||
| 005 | 20231226054420.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(22)01931-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1175.xml |
| 035 | |a (DE-627)NLM352740744 | ||
| 035 | |a (NLM)36764314 | ||
| 035 | |a (PII)S0140-6736(22)01931-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rollins, Nigel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Marketing of commercial milk formula |b a system to capture parents, communities, science, and policy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2023 | ||
| 500 | |a Date Revised 07.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Lancet. 2023 Aug 5;402(10400):445-446. - PMID 37543413 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. | ||
| 520 | |a Despite proven benefits, less than half of infants and young children globally are breastfed in accordance with the recommendations of WHO. In comparison, commercial milk formula (CMF) sales have increased to about US$55 billion annually, with more infants and young children receiving formula products than ever. This Series paper describes the CMF marketing playbook and its influence on families, health professionals, science, and policy processes, drawing on national survey data, company reports, case studies, methodical scoping reviews, and two multicountry research studies. We report how CMF sales are driven by multifaceted, well resourced marketing strategies that portray CMF products, with little or no supporting evidence, as solutions to common infant health and developmental challenges in ways that systematically undermine breastfeeding. Digital platforms substantially extend the reach and influence of marketing while circumventing the International Code of Marketing of Breast-milk Substitutes. Creating an enabling policy environment for breastfeeding that is free from commercial influence requires greater political commitment, financial investment, CMF industry transparency, and sustained advocacy. A framework convention on the commercial marketing of food products for infants and children is needed to end CMF marketing | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Piwoz, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Baker, Phillip |e verfasserin |4 aut | |
| 700 | 1 | |a Kingston, Gillian |e verfasserin |4 aut | |
| 700 | 1 | |a Mabaso, Kopano Matlwa |e verfasserin |4 aut | |
| 700 | 1 | |a McCoy, David |e verfasserin |4 aut | |
| 700 | 1 | |a Ribeiro Neves, Paulo Augusto |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Escamilla, Rafael |e verfasserin |4 aut | |
| 700 | 1 | |a Richter, Linda |e verfasserin |4 aut | |
| 700 | 1 | |a Russ, Katheryn |e verfasserin |4 aut | |
| 700 | 1 | |a Sen, Gita |e verfasserin |4 aut | |
| 700 | 1 | |a Tomori, Cecília |e verfasserin |4 aut | |
| 700 | 1 | |a Victora, Cesar G |e verfasserin |4 aut | |
| 700 | 1 | |a Zambrano, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Hastings, Gerard |e verfasserin |4 aut | |
| 700 | 0 | |a 2023 Lancet Breastfeeding Series Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 401(2023), 10375 vom: 11. Feb., Seite 486-502 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:401 |g year:2023 |g number:10375 |g day:11 |g month:02 |g pages:486-502 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(22)01931-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 401 |j 2023 |e 10375 |b 11 |c 02 |h 486-502 | ||